HomeInsightsStock Comparison

Acutaas Chemicals Ltd vs Cipla Ltd Stock Comparison

Acutaas Chemicals Ltd vs Cipla Ltd Stock Comparison

Last Updated on: Jun 14, 2025

Key Highlights

  • The Latest Trading Price of Ami Organics Ltd is ₹ 1104 as of 13 Jun 15:30.
  • The P/E Ratio of Ami Organics Ltd changed from 50.6 on March 2022 to 94.3 on March 2024 . This represents a CAGR of 23.06% over 3 yearsThe P/E Ratio of Cipla Ltd changed from 22 on March 2020 to 29.3 on March 2024 . This represents a CAGR of 5.90% over 5 years.
  • The Market Cap of Ami Organics Ltd changed from ₹ 3642 crore on March 2022 to ₹ 4036 crore on March 2024 . This represents a CAGR of 3.48% over 3 yearsThe Market Cap of Cipla Ltd changed from ₹ 34103 crore on March 2020 to ₹ 120673 crore on March 2024 . This represents a CAGR of 28.75% over 5 years.
  • The revenue of Ami Organics Ltd for the Mar '25 is ₹ 314.26 crore as compare to the Dec '24 revenue of ₹ 276.66 crore. This represent the growth of 13.59% The revenue of Cipla Ltd for the Mar '25 is ₹ 7019 crore as compare to the Dec '24 revenue of ₹ 7294 crore. This represent the decline of -3.78%.
  • The ebitda of Ami Organics Ltd for the Mar '25 is ₹ 90.74 crore as compare to the Dec '24 ebitda of ₹ 70.34 crore. This represent the growth of 29% The ebitda of Cipla Ltd for the Mar '25 is ₹ 1827 crore as compare to the Dec '24 ebitda of ₹ 2210 crore. This represent the decline of -17.35%.
  • The net profit of Ami Organics Ltd changed from ₹ 22.24 crore to ₹ 62.72 crore over 8 quarters. This represents a CAGR of 67.93% The net profit of Cipla Ltd changed from ₹ 996.58 crore to ₹ 1225 crore over 8 quarters. This represents a CAGR of 10.87% .
  • The Dividend Payout of Ami Organics Ltd changed from 15.19 % on March 2022 to 25.33 % on March 2024 . This represents a CAGR of 18.58% over 3 yearsThe Dividend Payout of Cipla Ltd changed from 14.24 % on March 2020 to 25.74 % on March 2024 . This represents a CAGR of 12.57% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ami Organics Ltd

  • Ami Organics Limited was initially formed as a partnership firm in the name of 'Ami Organics' with effect from 03 January, 2004 at Surat, India.
  • The Firm converted into a Private Limited Company under the name of 'Ami Organics Private Limited' with a Certificate of Incorporation dated 12 June, 2007.
  • Subsequently, the Company was converted into a Public Limited Company, following which the Company's name was changed to 'Ami Organics Limited', and a fresh Certificate of Incorporation was issued by RoC on April 18, 2018. The Company is engaged in business of drugs intermediate chemicals and related activities.
  • The Company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.
  • The Company Implemented the Integrated Management System (IMS) in 2011; it incorporated Ami OncoTheranostics, LLC in Delware, USA along with Photolitec LLC as a 50-50 JV in 2015.

About Cipla Ltd

  • Cipla Limited is one of the leading pharmaceutical companies in India.
  • The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).
  • Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments.
  • With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets.
  • Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories. Cipla Limited was incorporated in year 1935 with the name as 'Chemical, Industrial & Pharmaceutical Laboratories Limited'.

Ami Organics Ltd News Hub

News

Board of AMI Organics recommends final dividend

AMI Organics announced that the Board of Directors of the Company at its meeting held on 2...

Read more

02 May 2025 14:08

News

Ami Organics jumps after Q4 PAT soars to Rs 627 cr

Revenue from operations jumped 37.13% year on year to Rs 308.48 crore during the quarter e...

Read more

02 May 2025 14:49

News

AMI Organics to hold board meeting

AMI Organics will hold a meeting of the Board of Directors of the Company on 2 May 2025. P...

Read more

25 Apr 2025 11:18

News

Ami Organics' Unit II receives Japan PMDA nod for GMP compliance

Ami Organics' manufacturing facility, Unit II situated at Ankleshwar, which is involved in...

Read more

24 Apr 2025 15:57

News

AMI Organics to hold EGM

AMI Organics announced that an Extra Ordinary General Meeting (EGM) of the Company will be...

Read more

16 Apr 2025 20:44

News

Board of Ami Organics approves change in company name to Acutaas Chemicals

The Board of Ami Organics at its meeting held on 16 April 2025 has approved the change in ...

Read more

16 Apr 2025 15:03

Cipla Ltd News Hub

News

Cipla Ltd spurts 0.42%, up for fifth straight session

Cipla Ltd is up for a fifth straight session today. The stock is quoting at Rs 1517.2, up ...

Read more

11 Jun 2025 13:00

News

Jay Precision Pharmaceuticals acquires 26% stake in AMPIN Energy C&I Eighteen

Jay Precision Pharmaceuticals, subsidiary of Cipla, has completed acquisition of 26% stake...

Read more

29 May 2025 18:48

News

Cipla announced incorporation of subsidiary - CiplaRna GmbH' in Germany

Cipla announced that Cipla (EU), UK, a wholly owned subsidiary of the Company, has incorpo...

Read more

29 May 2025 18:50

News

Cipla to convene AGM

Cipla announced that the 89th Annual General Meeting(AGM) of the company will be held on 1...

Read more

14 May 2025 15:08

News

Board of Cipla recommends final dividend

Cipla announced that the Board of Directors of the Company at its meeting held on 13 May 2...

Read more

13 May 2025 14:34

News

Board of Cipla recommends special dividend

Cipla announced that the Board of Directors of the Company at its meeting held on 13 May 2...

Read more

13 May 2025 14:34

SWOT Analysis Of Ami Organics Ltd

Strength

5

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Cipla Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Ami Organics Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Cipla Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ami Organics Ltd and Cipla Ltd

Which company has a larger market capitalization, Ami Organics Ltd or Cipla Ltd?

Market cap of Ami Organics Ltd is 9,039 Cr while Market cap of Cipla Ltd is 121,589 Cr

What are the key factors driving the stock performance of Ami Organics Ltd and Cipla Ltd?

The stock performance of Ami Organics Ltd and Cipla Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ami Organics Ltd and Cipla Ltd?

As of June 14, 2025, the Ami Organics Ltd stock price is INR ₹1104.15. On the other hand, Cipla Ltd stock price is INR ₹1505.4.

How do dividend payouts of Ami Organics Ltd and Cipla Ltd compare?

To compare the dividend payouts of Ami Organics Ltd and Cipla Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions